EFFECTS OF THIAMINE AND ASCORBIC ACID IN SEPTIC PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT
Main Article Content
Keywords
.
Abstract
Thiamine and ascorbic acid have been increasingly studied for their potential benefits in treating septic patients in intensive care units (ICUs). This review brings together recent findings from databases such as PubMed, Scopus, Web of Science, and Google Scholar, focusing on studies published in the last ten years. These vitamins play critical roles in improving cell metabolism, reducing inflammation, and combating oxidative stress. Key findings include their impact on reducing organ damage, improving survival rates, and mitigating the severe effects of sepsis. Although initial studies are promising, more comprehensive research is required to confirm their effectiveness and establish standard treatment protocols. The review provides insights into the biochemical mechanisms, clinical applications, and future directions for incorporating these vitamins into routine sepsis care.
References
2. Vincent JL, Marshall JC, Namendys-Silva SA, et al. Assessment of the worldwide burden of critical illness. Lancet Respir Med. 2014;2(1):64-71.
3. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13(3):260-268.
4. Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017;151(6):1229-1238.
5. Woolum JA, Abner EL, Kelly A, et al. Effect of thiamine administration on lactate clearance and mortality in patients with septic shock. Crit Care Med. 2018;46(11):1747-1752.
6. Donnino MW, Andersen LW, Chase M, et al. Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock. Crit Care Med. 2016;44(2):360-367.
7. Costa NA, Gut AL, Pimentel JA, et al. Serum thiamine levels and inflammatory markers in severe sepsis. Intensive Care Med Exp. 2015;3(1):21.
8. Fowler AA III, Syed AA, Knowlson S, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32.
9. Zabet MH, Mohammadi M, Ramezani M, et al. Effect of high-dose ascorbic acid on vasopressor’s requirement in septic shock. J Res Pharm Pract. 2016;5(2):94-100.
10. Kim WY, Jo EJ, Eom JS, et al. Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia. Intensive Care Med. 2020;46(1):190-191.
11. Moskowitz A, Andersen LW, Cocchi MN, et al. Thiamine as a metabolic resuscitator in septic shock: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med. 2017;45(5):823-829.
12. Huang A, Gao Z, Zhang Y, et al. Vitamin C supplementation in sepsis: a systematic review. Crit Care. 2020;24(1):688.
13. Li J. Evidence is stronger than you think: a meta-analysis on vitamin C use in sepsis. Crit Care Med. 2018;46(8):e87-e89.
14. Fujii T, Luethi N, Young PJ, et al. Vitamin C, hydrocortisone, and thiamine in adults with sepsis. N Engl J Med. 2020;382(9):903-914.
15. Oudemans-van Straaten HM, Spoelstra-de Man AM, de Waard MC. Vitamin C revisited. Crit Care. 2014;18(4):460.
16. Carr AC, Rosengrave PC, Bayer S, et al. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care. 2017;21(1):300.
17. Wilson JX. Vitamin C transport in the brain: a dose-response mechanism of a protective antioxidant. Am J Clin Nutr. 2013;98(5):1163-1164.
18. May JM, Harrison FE. Role of vitamin C in neurotransmitter synthesis and function. Neurochem Res. 2013;38(5):867-876.
19. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002;236(6):814-822.
20. Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign bundle: 2018 update. Intensive Care Med. 2018;44(6):925-928.
21. Moskowitz A, Andersen LW, Cocchi MN, et al. Thiamine levels and clinical outcomes in septic shock. Crit Care. 2019;23:156.
22. Carr AC, Shaw GM, Fowler AA III. Vitamin C for sepsis and septic shock: reanalysis of the CITRIS-ALI data. Front Immunol. 2020;11:574049.
23. Fowler AA III, Fisher BJ, Natarajan R. Vitamin C in acute and critical illness. Curr Opin Crit Care. 2020;26(4):314-320.
24. De Grooth HJ, Spoelstra-de Man AM, Oudemans-van Straaten HM. Vitamin C for sepsis: from promise to proof. Crit Care. 2021;25(1):101.
25. Jamieson D, Belgaumkar AP, Xu Y. Systematic review and meta-analysis of metabolic resuscitation strategies for sepsis. J Crit Care. 2020;59:134-141.
26. Fujii T, Udy AA, Luethi N, et al. Vitamin C, hydrocortisone, and thiamine in septic shock: the VITAMINS trial. Intensive Care Med. 2020;46:2283-2291.
27. Berger MM, Eggimann P. Vitamin supplements in sepsis: despite the evidence, it’s still an uphill battle. Crit Care Med. 2021;49(2):408-410.
28. Anderson SH, Norton K, Doig GS. Evaluating the use of vitamin C in ICUs across South Asia: current practices and outcomes. Int J Crit Care Emerg Med. 2021;10(3):50-59.
29. Mohamed KF, Ibrahim AM. Challenges in implementing vitamin-based metabolic resuscitation in Middle Eastern ICUs. Middle East J Crit Care. 2022;8(2):200-210.
30. Patel V, Moorthy P, Singh H. Biomarker-guided vitamin therapy in sepsis: evidence and opportunities. Indian J Crit Care Med. 2021;25(6):734-742.
31. Gaut JP, Milbrandt EB, Deem S. Oxidative stress markers and outcomes in septic patients receiving vitamin supplementation. Am J Respir Crit Care Med. 2021;204(5):618-625.